038 - Suvarexant (Belsomra) - a new drug class for insomnia
In this episode, we discuss suvarexant (Belsomra), the first dual orexin receptor antagonist approved in the United States for the treatment of insomnia.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/helixtalk\/038_-_Belsomra_suvarexant.mp3?dest-id=187168","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202310\/51d8ce-5810-087d-300941_800.png"},"title":"038 - Suvarexant (Belsomra) - a new drug class for insomnia","link":"javascript:;","id":"item-685467"}]
